Literature DB >> 6374012

Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

H Perlmann, K Berzins, M Wahlgren, J Carlsson, A Björkman, M E Patarroyo, P Perlmann.   

Abstract

Monolayers of human erythrocytes (E) infected with Plasmodium falciparum were briefly fixed with 1% glutaraldehyde and air dried. They were then exposed to sera from patients with P. falciparum malaria or from donors immune to this parasite and tested in an indirect immunofluorescence assay (IFA). Parasites in infected E were made visible by counterstaining with ethidium bromide. Immunofluorescence (IF) was restricted to the surface of infected E. No antibody binding was detected unless the E were dried, suggesting that the relevant antigens were not available on the outer layers of the E surface. Staining over large parts of the E surface was seen already when the merozoite penetrated noninfected cells and was strong in E containing early stages of the parasite (rings, trophozoites). It was weak or absent from E containing schizonts. Antibodies in sera from different parts of Africa, Colombia, or Sweden reacted similarly with E infected with a Tanzanian P. falciparum strain kept in culture for many years and with parasitized E freshly drawn from African, Swedish, or Colombian patients. All sera from residents of a holoendemic area (Liberia) were IFA positive. In contrast, some sera from Colombian or Swedish patients with primary infection gave negative results. The results of the IFA and of an enzyme-linked immunosorbent assay in which fixed and dried E were the targets were well-correlated, suggesting that the same antibodies were detected by these assays. The antigens involved in the IFA were susceptible to pronase but not to trypsin or neuraminidase. E surface IF was inhibited by lysates of infected E, merozoite extracts, or soluble antigens present in P. falciparum culture supernatants but not by lysates of normal E or ghost extracts. The inhibitory antigens were heat stable (100 degrees C, 5 min). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by immunoblotting of either antigen-enriched preparations from culture supernatants or merozoite extracts showed that antibodies eluted from monolayers of infected E reacted consistently with a predominant polypeptide of Mr 155,000 and two to four minor polypeptides of lower molecular weights. Metabolic labeling of the parasites with 75Se-methionine indicated that these antigens were parasite derived. We conclude that the antigens involved in these reactions are released from bursting schizonts or merozoites and are deposited in the E membrane in the course of invasion.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374012      PMCID: PMC2187329          DOI: 10.1084/jem.159.6.1686

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi.

Authors:  K N Brown; I N Brown
Journal:  Nature       Date:  1965-12-25       Impact factor: 49.962

2.  Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes.

Authors:  R J Howard; J W Barnwell; V Kao
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

3.  Characterization of an S antigen synthesized by several isolates of Plasmodium falciparum.

Authors:  R F Anders; G V Brown; A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  Lectin-like polypeptides of P. falciparum bind to red cell sialoglycoproteins.

Authors:  M Jungery; D Boyle; T Patel; G Pasvol; D J Weatherall
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

5.  Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi.

Authors:  J Ellis; L S Ozaki; R W Gwadz; A H Cochrane; V Nussenzweig; R S Nussenzweig; G N Godson
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

6.  Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells.

Authors:  I J Udeinya; L H Miller; I A McGregor; J B Jensen
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

7.  Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.

Authors:  K Lundgren; M Wahlgren; M Troye-Blomberg; K Berzins; H Perlmann; P Perlmann
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

8.  Characterization of the humoral immune response in Plasmodium falciparum malaria. I. Estimation of antibodies to P. falciparum or human erythrocytes by means of microELISA.

Authors:  M Wahlgren; K Berzins; P Perlmann; A Björkman
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

9.  Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen.

Authors:  M Hommel; P H David; L D Oligino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

10.  Protective Plasmodium knowlesi Mr 74,000 antigen in membranes of schizont-infected rhesus erythrocytes.

Authors:  R Schmidt-Ullrich; J Lightholder; M T Monroe
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  74 in total

1.  Role of calcium and erythrocyte cytoskeleton phosphorylation in the invasion of Plasmodium falciparum.

Authors:  M Wasserman; J P Vernot; P M Mendoza
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

2.  Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.

Authors:  M Troye-Blomberg; E M Riley; L Kabilan; M Holmberg; H Perlmann; U Andersson; C H Heusser; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Movement of a falciparum malaria protein through the erythrocyte cytoplasm to the erythrocyte membrane is associated with lysis of the erythrocyte and release of gametes.

Authors:  I A Quakyi; Y Matsumoto; R Carter; R Udomsangpetch; A Sjolander; K Berzins; P Perlmann; M Aikawa; L H Miller
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate.

Authors:  C L Mintzer; P Deloron; A Rice-Ficht; D Durica; D K Struck; C A Roessner; C Nicolau; G M Ihler
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

Review 5.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

6.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

7.  Genetic regulation of human anti-malarial antibodies in twins.

Authors:  K Sjöberg; J P Lepers; L Raharimalala; A Larsson; O Olerup; N T Marbiah; M Troye-Blomberg; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Studies of murine malaria antigens using monoclonal antibodies. Production, selection, and characterization of antibodies.

Authors:  G Holmquist; P Borwell; A R Cattan; H Wigzell
Journal:  Z Parasitenkd       Date:  1986

9.  Glycoprotein recognition mediates attachment of Plasmodium chabaudi to mouse erythrocytes.

Authors:  M H Rodriguez; M Jungery
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

10.  Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.

Authors:  L Kabilan; V P Sharma; P Kaur; S K Ghosh; R S Yadav; V S Chauhan
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.